These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37468452)

  • 1. Sodium-glucose co-transporter-2 inhibitor use and erythrocytosis: assessment of risk and need for referral to haematology.
    Gangat N; Tefferi A
    Nephrol Dial Transplant; 2023 Nov; 38(12):2670-2672. PubMed ID: 37468452
    [No Abstract]   [Full Text] [Related]  

  • 2. SGLT2 Inhibitor-Related Polycythemia in a Patient With Chronic Heart Failure: A Potential Severe Adverse Event.
    Tukker M; Bruwiere E; Bos S; Caliskan K
    Circ Heart Fail; 2023 Jul; 16(7):e010613. PubMed ID: 37317887
    [No Abstract]   [Full Text] [Related]  

  • 3. Sodium-glucose co-transporter-2 inhibitor use and JAK2 unmutated erythrocytosis in 100 consecutive cases.
    Gangat N; Abdallah M; Szuber N; Saliba A; Alkhateeb H; Al-Kali A; Begna KH; Pardanani A; Tefferi A
    Am J Hematol; 2023 Jul; 98(7):E165-E167. PubMed ID: 37073574
    [No Abstract]   [Full Text] [Related]  

  • 4. Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and uric acid: More good news!
    Katsiki N; Rizzo M; Mikhailidis DP
    J Diabetes Complications; 2023 Jul; 37(7):108510. PubMed ID: 37235924
    [No Abstract]   [Full Text] [Related]  

  • 5. Marked erythrocytosis during treatment with sodium glucose cotransporter-2 inhibitors-report of two cases.
    Gupta R; Gupta A; Shrikhande M; Tyagi K; Ghosh A; Misra A
    Diabetes Res Clin Pract; 2020 Apr; 162():108127. PubMed ID: 32224163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Erythrocytosis During Concomitant Testosterone and SGLT2-Inhibitor Treatment: A Warning From Two Clinical Cases.
    Motta G; Zavattaro M; Romeo F; Lanfranco F; Broglio F
    J Clin Endocrinol Metab; 2019 Mar; 104(3):819-822. PubMed ID: 30395251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of sodium-glucose co-transporter-2 inhibitors in patients with kidney transplantation and diabetes mellitus.
    Yeggalam A; Liebich JA; Yu K; Shrestha E; Nadella S; Ahir V; Newman J; Lentine KL; Caliskan Y; Abu Al Rub F; Dhindsa S; Albert SG
    Diabetes Obes Metab; 2023 Jun; 25(6):1777-1780. PubMed ID: 36846956
    [No Abstract]   [Full Text] [Related]  

  • 8. A hypothesis for why sodium glucose co-transporter 2 inhibitors have been found to cause genital infection, but not urinary tract infection.
    Fralick M; MacFadden DR
    Diabetes Obes Metab; 2020 May; 22(5):755-758. PubMed ID: 31943733
    [No Abstract]   [Full Text] [Related]  

  • 9. Updated meta-analysis assessing the risk of amputation with sodium-glucose co-transporter-2 inhibitors in the hallmark cardiovascular and renal outcome trials.
    Patoulias D; Papadopoulos C; Doumas M
    Diabetes Obes Metab; 2021 Apr; 23(4):1063-1065. PubMed ID: 33319468
    [No Abstract]   [Full Text] [Related]  

  • 10. Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: Do we really need sodium increase, especially in sepsis?
    Patoulias D
    Crit Care; 2023 May; 27(1):204. PubMed ID: 37237403
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of cost-effectiveness in the use of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists.
    Liu M; Hao G
    Eur J Prev Cardiol; 2023 Jun; 30(8):656-657. PubMed ID: 36740456
    [No Abstract]   [Full Text] [Related]  

  • 12. SGLT2 inhibitors increase risk for diabetic ketoacidosis in type 2 diabetes.
    Griffin TP; Dinneen SF
    Ann Intern Med; 2020 Oct; 173(8):JC40. PubMed ID: 33075260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empagliflozin for Patients with Heart Failure and Type 2 Diabetes Mellitus: Clinical Evidence in Comparison with Other Sodium-Glucose Co-transporter-2 Inhibitors and Potential Mechanism.
    Liang B; Li R; Zhang P; Gu N
    J Cardiovasc Transl Res; 2023 Apr; 16(2):327-340. PubMed ID: 35969357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: A population-based cohort study.
    van Dalem J; Werkman NCC; van den Bergh JP; Rossi B; Viggers R; Eastell R; Burden AM; Stehouwer CDA; Klungel OH; Brouwers MCGJ; Driessen JHM
    Diabetes Res Clin Pract; 2022 Aug; 190():109993. PubMed ID: 35842030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium-glucose co-transporter-2 inhibitors: know the patient and the drugs.
    Lim LL; Chan JCN
    Hong Kong Med J; 2019 Aug; 25(4):268-270. PubMed ID: 31416989
    [No Abstract]   [Full Text] [Related]  

  • 16. Sodium-glucose co-transporter type-2 inhibitors: is the message getting through? A reply.
    Nathanson M
    Anaesthesia; 2019 May; 74(5):680. PubMed ID: 30957885
    [No Abstract]   [Full Text] [Related]  

  • 17. Is there any place for sodium-glucose co-transporter-2 inhibitors in post-liver transplantation patients?
    Patoulias D; Katsimardou A; Kalogirou MS; Karagiannis A; Doumas M
    Dig Liver Dis; 2020 Feb; 52(2):239-240. PubMed ID: 31787555
    [No Abstract]   [Full Text] [Related]  

  • 18. Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply.
    Mårtensson J; Bellomo R
    Crit Care; 2023 Jun; 27(1):225. PubMed ID: 37291591
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of sodium-glucose co-transporter (SGLT)-2 inhibitors in heart failure management and implications for the kidneys.
    Lioudaki E; Joslin JR; Trachanatzi E; Androulakis E
    Rev Cardiovasc Med; 2022 Mar; 23(3):82. PubMed ID: 35345249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium-glucose co-transporter 2 inhibitors and hematopoiesis.
    Yaribeygi H; Maleki M; Nasimi F; Butler AE; Jamialahmadi T; Sahebkar A
    J Cell Physiol; 2022 Oct; 237(10):3778-3787. PubMed ID: 35951776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.